glp-1 and type 1 diabetes receptor agonists GLP-1RAs Reduce External Eating Behavior

The SURPASS-2 trial showing tirzepatide achieving significantly greater HbA1c reduction and weight loss than semaglutide in T2DM patients, and the SURMOUNT trials showing up to 22% average body weight reduction in obese patients, have established tirzepatide as the clinical performance leader in the class

Sources: All data and statements above are based on current industry news, company releases, and expert analyses

1 GLP-1 receptor agonists (GLP-1 RAs) medications like Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Trulicity, and Victoza are designed to mimic the GLP-1 hormone and amplify its effects

Our team of licensed US providers will check in with you regularly to see how youre responding and feeling

Bifari F, Manfrini R, Dei Cas M, Berra C, Siano M, Zuin M, et al